HEADER MEMBRANE PROTEIN 26-JUL-22 8DU3 TITLE CRYSTAL STRUCTURE OF A2AAR-STAR2-BRIL IN COMPLEX WITH COMPOUND 21A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENOSINE RECEPTOR A2A, SOLUBLE CYTOCHROME B562 CHIMERA, COMPND 3 SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: CYTOCHROME B-562; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADORA2A, ADORA2, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, LCP, ANTAGONISTS, ALZHEIMER, PARKINSON, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.SHIRIAEVA,B.STAUCH,G.W.HAN,V.CHEREZOV REVDAT 3 18-OCT-23 8DU3 1 REMARK REVDAT 2 24-AUG-22 8DU3 1 JRNL REVDAT 1 10-AUG-22 8DU3 0 JRNL AUTH R.BOLTEAU,R.DUROUX,A.LAVERSIN,B.VREULZ,A.SHIRIAEVA,B.STAUCH, JRNL AUTH 2 G.W.HAN,V.CHEREZOV,N.RENAULT,A.BARCZYK,S.RAVEZ,M.COEVOET, JRNL AUTH 3 P.MELNYK,M.LIBERELLE,S.YOUS JRNL TITL HIGH LIGAND EFFICIENCY QUINAZOLINE COMPOUNDS AS NOVEL A 2A JRNL TITL 2 ADENOSINE RECEPTOR ANTAGONISTS. JRNL REF EUR.J.MED.CHEM. V. 241 14620 2022 JRNL REFN ISSN 0223-5234 JRNL PMID 35933788 JRNL DOI 10.1016/J.EJMECH.2022.114620 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 17798 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 896 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.8300 - 4.5400 0.98 2959 154 0.1962 0.2314 REMARK 3 2 4.5400 - 3.6100 0.99 2829 153 0.1596 0.2099 REMARK 3 3 3.6100 - 3.1500 0.99 2831 159 0.1880 0.2113 REMARK 3 4 3.1500 - 2.8600 1.00 2779 158 0.1887 0.2413 REMARK 3 5 2.8600 - 2.6600 1.00 2796 147 0.2069 0.2603 REMARK 3 6 2.6600 - 2.5000 0.97 2708 125 0.2509 0.3231 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 0 THROUGH 208) REMARK 3 ORIGIN FOR THE GROUP (A): -24.1097 -5.5656 21.0910 REMARK 3 T TENSOR REMARK 3 T11: 0.2264 T22: 0.2790 REMARK 3 T33: 0.2187 T12: -0.0134 REMARK 3 T13: -0.0008 T23: 0.0241 REMARK 3 L TENSOR REMARK 3 L11: 0.3864 L22: 0.4540 REMARK 3 L33: 1.0119 L12: 0.2844 REMARK 3 L13: 0.2110 L23: 0.4907 REMARK 3 S TENSOR REMARK 3 S11: -0.0378 S12: -0.0484 S13: 0.0564 REMARK 3 S21: 0.0168 S22: 0.0391 S23: 0.0141 REMARK 3 S31: 0.0452 S32: -0.1378 S33: -0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 1001 THROUGH 1106 ) REMARK 3 ORIGIN FOR THE GROUP (A): 0.5139 -54.6974 20.0043 REMARK 3 T TENSOR REMARK 3 T11: 0.4832 T22: 0.3772 REMARK 3 T33: 0.8574 T12: 0.0919 REMARK 3 T13: -0.0263 T23: -0.0205 REMARK 3 L TENSOR REMARK 3 L11: 0.1704 L22: 0.4856 REMARK 3 L33: 0.4169 L12: -0.1583 REMARK 3 L13: 0.0146 L23: -0.1166 REMARK 3 S TENSOR REMARK 3 S11: 0.1268 S12: -0.1769 S13: 0.4208 REMARK 3 S21: -0.2746 S22: 0.0516 S23: -0.0045 REMARK 3 S31: -0.2581 S32: -0.0344 S33: 0.3050 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 219 THROUGH 306) REMARK 3 ORIGIN FOR THE GROUP (A): -18.0304 -10.6190 11.0892 REMARK 3 T TENSOR REMARK 3 T11: 0.2910 T22: 0.2532 REMARK 3 T33: 0.2320 T12: -0.0006 REMARK 3 T13: 0.0332 T23: -0.0128 REMARK 3 L TENSOR REMARK 3 L11: 0.3080 L22: 0.1209 REMARK 3 L33: 0.7113 L12: -0.0875 REMARK 3 L13: 0.2799 L23: -0.2135 REMARK 3 S TENSOR REMARK 3 S11: -0.0060 S12: 0.0344 S13: 0.0081 REMARK 3 S21: -0.3349 S22: 0.0145 S23: -0.1387 REMARK 3 S31: 0.0475 S32: 0.0522 S33: 0.0001 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DU3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1000267352. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 123 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19347 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.15600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 1.02000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4EIY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE PH 4.5, SODIUM REMARK 280 THIOCYANATE, PEG 400, 2,4-HEXANEDIOL, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.50000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.50000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 19.80000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 89.90000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 19.80000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 89.90000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.50000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 19.80000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 89.90000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.50000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 19.80000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 89.90000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE AUTHOR STATES THAT THE BIOLOGICAL UNIT OF THIS PROTEIN REMARK 300 IS UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -24 REMARK 465 LYS A -23 REMARK 465 THR A -22 REMARK 465 ILE A -21 REMARK 465 ILE A -20 REMARK 465 ALA A -19 REMARK 465 LEU A -18 REMARK 465 SER A -17 REMARK 465 TYR A -16 REMARK 465 ILE A -15 REMARK 465 PHE A -14 REMARK 465 CYS A -13 REMARK 465 LEU A -12 REMARK 465 VAL A -11 REMARK 465 PHE A -10 REMARK 465 ALA A -9 REMARK 465 ASP A -8 REMARK 465 TYR A -7 REMARK 465 LYS A -6 REMARK 465 ASP A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 GLY A -1 REMARK 465 THR A 1044 REMARK 465 PRO A 1045 REMARK 465 PRO A 1046 REMARK 465 LYS A 1047 REMARK 465 LEU A 1048 REMARK 465 GLU A 1049 REMARK 465 ASP A 1050 REMARK 465 LYS A 1051 REMARK 465 SER A 1052 REMARK 465 PRO A 1053 REMARK 465 ASP A 1054 REMARK 465 SER A 1055 REMARK 465 PRO A 1056 REMARK 465 VAL A 307 REMARK 465 LEU A 308 REMARK 465 ARG A 309 REMARK 465 GLN A 310 REMARK 465 GLN A 311 REMARK 465 GLU A 312 REMARK 465 PRO A 313 REMARK 465 PHE A 314 REMARK 465 LYS A 315 REMARK 465 ALA A 316 REMARK 465 HIS A 317 REMARK 465 HIS A 318 REMARK 465 HIS A 319 REMARK 465 HIS A 320 REMARK 465 HIS A 321 REMARK 465 HIS A 322 REMARK 465 HIS A 323 REMARK 465 HIS A 324 REMARK 465 HIS A 325 REMARK 465 HIS A 326 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 199 NH1 NH2 REMARK 470 ARG A 206 CD NE CZ NH1 NH2 REMARK 470 LYS A1042 CG CD CE NZ REMARK 470 MET A1058 CG SD CE REMARK 470 LYS A1059 CG CD CE NZ REMARK 470 LYS A1104 CG CD CE NZ REMARK 470 ARG A 220 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 293 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 58 -51.88 -130.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 3005 REMARK 610 OLC A 3006 REMARK 610 OLC A 3007 REMARK 610 OLC A 3008 REMARK 610 OLA A 3009 REMARK 610 OLA A 3011 REMARK 610 OLA A 3012 REMARK 610 OLA A 3015 REMARK 610 OLA A 3016 REMARK 610 OLA A 3017 REMARK 610 OLA A 3018 REMARK 610 OLA A 3020 REMARK 610 OLA A 3022 REMARK 610 OLA A 3023 REMARK 610 OLA A 3025 DBREF 8DU3 A 2 208 UNP P29274 AA2AR_HUMAN 2 208 DBREF 8DU3 A 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 8DU3 A 219 316 UNP P29274 AA2AR_HUMAN 219 316 SEQADV 8DU3 MET A -24 UNP P29274 INITIATING METHIONINE SEQADV 8DU3 LYS A -23 UNP P29274 EXPRESSION TAG SEQADV 8DU3 THR A -22 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ILE A -21 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ILE A -20 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ALA A -19 UNP P29274 EXPRESSION TAG SEQADV 8DU3 LEU A -18 UNP P29274 EXPRESSION TAG SEQADV 8DU3 SER A -17 UNP P29274 EXPRESSION TAG SEQADV 8DU3 TYR A -16 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ILE A -15 UNP P29274 EXPRESSION TAG SEQADV 8DU3 PHE A -14 UNP P29274 EXPRESSION TAG SEQADV 8DU3 CYS A -13 UNP P29274 EXPRESSION TAG SEQADV 8DU3 LEU A -12 UNP P29274 EXPRESSION TAG SEQADV 8DU3 VAL A -11 UNP P29274 EXPRESSION TAG SEQADV 8DU3 PHE A -10 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ALA A -9 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ASP A -8 UNP P29274 EXPRESSION TAG SEQADV 8DU3 TYR A -7 UNP P29274 EXPRESSION TAG SEQADV 8DU3 LYS A -6 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ASP A -5 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ASP A -4 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ASP A -3 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ASP A -2 UNP P29274 EXPRESSION TAG SEQADV 8DU3 GLY A -1 UNP P29274 EXPRESSION TAG SEQADV 8DU3 ALA A 0 UNP P29274 EXPRESSION TAG SEQADV 8DU3 PRO A 1 UNP P29274 EXPRESSION TAG SEQADV 8DU3 LEU A 54 UNP P29274 ALA 54 ENGINEERED MUTATION SEQADV 8DU3 ALA A 88 UNP P29274 THR 88 ENGINEERED MUTATION SEQADV 8DU3 ALA A 107 UNP P29274 ARG 107 ENGINEERED MUTATION SEQADV 8DU3 ALA A 122 UNP P29274 LYS 122 ENGINEERED MUTATION SEQADV 8DU3 ALA A 154 UNP P29274 ASN 154 ENGINEERED MUTATION SEQADV 8DU3 ALA A 202 UNP P29274 LEU 202 ENGINEERED MUTATION SEQADV 8DU3 TRP A 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 8DU3 ILE A 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 8DU3 LEU A 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 8DU3 ALA A 235 UNP P29274 LEU 235 ENGINEERED MUTATION SEQADV 8DU3 ALA A 239 UNP P29274 VAL 239 ENGINEERED MUTATION SEQADV 8DU3 ALA A 277 UNP P29274 SER 277 ENGINEERED MUTATION SEQADV 8DU3 HIS A 317 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 318 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 319 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 320 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 321 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 322 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 323 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 324 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 325 UNP P29274 EXPRESSION TAG SEQADV 8DU3 HIS A 326 UNP P29274 EXPRESSION TAG SEQRES 1 A 447 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 A 447 VAL PHE ALA ASP TYR LYS ASP ASP ASP ASP GLY ALA PRO SEQRES 3 A 447 PRO ILE MET GLY SER SER VAL TYR ILE THR VAL GLU LEU SEQRES 4 A 447 ALA ILE ALA VAL LEU ALA ILE LEU GLY ASN VAL LEU VAL SEQRES 5 A 447 CYS TRP ALA VAL TRP LEU ASN SER ASN LEU GLN ASN VAL SEQRES 6 A 447 THR ASN TYR PHE VAL VAL SER LEU ALA ALA ALA ASP ILE SEQRES 7 A 447 LEU VAL GLY VAL LEU ALA ILE PRO PHE ALA ILE THR ILE SEQRES 8 A 447 SER THR GLY PHE CYS ALA ALA CYS HIS GLY CYS LEU PHE SEQRES 9 A 447 ILE ALA CYS PHE VAL LEU VAL LEU ALA GLN SER SER ILE SEQRES 10 A 447 PHE SER LEU LEU ALA ILE ALA ILE ASP ARG TYR ILE ALA SEQRES 11 A 447 ILE ALA ILE PRO LEU ARG TYR ASN GLY LEU VAL THR GLY SEQRES 12 A 447 THR ARG ALA ALA GLY ILE ILE ALA ILE CYS TRP VAL LEU SEQRES 13 A 447 SER PHE ALA ILE GLY LEU THR PRO MET LEU GLY TRP ASN SEQRES 14 A 447 ASN CYS GLY GLN PRO LYS GLU GLY LYS ALA HIS SER GLN SEQRES 15 A 447 GLY CYS GLY GLU GLY GLN VAL ALA CYS LEU PHE GLU ASP SEQRES 16 A 447 VAL VAL PRO MET ASN TYR MET VAL TYR PHE ASN PHE PHE SEQRES 17 A 447 ALA CYS VAL LEU VAL PRO LEU LEU LEU MET LEU GLY VAL SEQRES 18 A 447 TYR LEU ARG ILE PHE ALA ALA ALA ARG ARG GLN LEU ALA SEQRES 19 A 447 ASP LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN LEU SEQRES 20 A 447 LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL LYS SEQRES 21 A 447 ASP ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP ALA SEQRES 22 A 447 GLN LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER PRO SEQRES 23 A 447 ASP SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE ASP SEQRES 24 A 447 ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA SEQRES 25 A 447 ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU SEQRES 26 A 447 GLN LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS TYR SEQRES 27 A 447 LEU GLU ARG ALA ARG SER THR LEU GLN LYS GLU VAL HIS SEQRES 28 A 447 ALA ALA LYS SER ALA ALA ILE ILE ALA GLY LEU PHE ALA SEQRES 29 A 447 LEU CYS TRP LEU PRO LEU HIS ILE ILE ASN CYS PHE THR SEQRES 30 A 447 PHE PHE CYS PRO ASP CYS SER HIS ALA PRO LEU TRP LEU SEQRES 31 A 447 MET TYR LEU ALA ILE VAL LEU ALA HIS THR ASN SER VAL SEQRES 32 A 447 VAL ASN PRO PHE ILE TYR ALA TYR ARG ILE ARG GLU PHE SEQRES 33 A 447 ARG GLN THR PHE ARG LYS ILE ILE ARG SER HIS VAL LEU SEQRES 34 A 447 ARG GLN GLN GLU PRO PHE LYS ALA HIS HIS HIS HIS HIS SEQRES 35 A 447 HIS HIS HIS HIS HIS HET TKO A3001 17 HET CLR A3002 28 HET CLR A3003 28 HET CLR A3004 28 HET OLC A3005 23 HET OLC A3006 16 HET OLC A3007 21 HET OLC A3008 20 HET OLA A3009 18 HET OLA A3010 20 HET OLA A3011 11 HET OLA A3012 9 HET OLA A3013 20 HET OLA A3014 20 HET OLA A3015 11 HET OLA A3016 8 HET OLA A3017 7 HET OLA A3018 11 HET OLA A3019 20 HET OLA A3020 11 HET OLA A3021 20 HET OLA A3022 17 HET OLA A3023 13 HET OLA A3024 20 HET OLA A3025 14 HETNAM TKO (4M)-6-BROMO-4-(FURAN-2-YL)QUINAZOLIN-2-AMINE HETNAM CLR CHOLESTEROL HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM OLA OLEIC ACID HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 TKO C12 H8 BR N3 O FORMUL 3 CLR 3(C27 H46 O) FORMUL 6 OLC 4(C21 H40 O4) FORMUL 10 OLA 17(C18 H34 O2) FORMUL 27 HOH *51(H2 O) HELIX 1 AA1 PRO A 1 ASN A 34 1 34 HELIX 2 AA2 SER A 35 GLN A 38 5 4 HELIX 3 AA3 ASN A 39 LEU A 58 1 20 HELIX 4 AA4 LEU A 58 THR A 68 1 11 HELIX 5 AA5 CYS A 74 ILE A 108 1 35 HELIX 6 AA6 ARG A 111 VAL A 116 1 6 HELIX 7 AA7 THR A 117 LEU A 137 1 21 HELIX 8 AA8 THR A 138 GLY A 142 5 5 HELIX 9 AA9 LYS A 150 GLN A 157 1 8 HELIX 10 AB1 LEU A 167 VAL A 172 1 6 HELIX 11 AB2 PRO A 173 TYR A 179 1 7 HELIX 12 AB3 VAL A 186 LYS A 1019 1 42 HELIX 13 AB4 ASN A 1022 ALA A 1043 1 22 HELIX 14 AB5 MET A 1058 GLY A 1082 1 25 HELIX 15 AB6 LYS A 1083 GLN A 1093 1 11 HELIX 16 AB7 GLN A 1093 TYR A 1101 1 9 HELIX 17 AB8 TYR A 1101 CYS A 259 1 47 HELIX 18 AB9 PRO A 266 ILE A 292 1 27 HELIX 19 AC1 ILE A 292 HIS A 306 1 15 SHEET 1 AA1 2 CYS A 71 ALA A 73 0 SHEET 2 AA1 2 GLN A 163 ALA A 165 -1 O VAL A 164 N ALA A 72 SSBOND 1 CYS A 71 CYS A 159 1555 1555 2.03 SSBOND 2 CYS A 74 CYS A 146 1555 1555 2.03 SSBOND 3 CYS A 77 CYS A 166 1555 1555 2.03 SSBOND 4 CYS A 259 CYS A 262 1555 1555 2.03 CRYST1 39.600 179.800 141.000 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025253 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005562 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007092 0.00000